Feasibility of a video-based cognitive behavioral therapy for insomnia in French adult cancer outpatients: results from the Sleep-4-All-1 study.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 14 10 2020
accepted: 15 03 2021
pubmed: 25 3 2021
medline: 16 10 2021
entrez: 24 3 2021
Statut: ppublish

Résumé

Insomnia affects up to 63% of patients with cancer. Cognitive behavioral therapy for insomnia (CBT-I) is considered to be the non-pharmacological gold standard treatment, but it remains underutilized in France. Self-administered interventions offer new ways to overcome some of the barriers that restrict access to efficacious supportive care. To assess the feasibility, among French adult cancer outpatients, of a validated Quebec video-based, self-administered, cognitive behavioral therapy for insomnia (VCBT-I). A pre-post design with quantitative measures (Insomnia Severity Index, Edmonton Symptom Assessment System, Treatment Perception Questionnaire) and qualitative measures (semi-structured interviews) was used. One hundred and seventy-three cancer outpatients were self-screened for insomnia, and 57% (n=99) reported significant symptoms. Among them, 80% (n=79) agreed to participate in the VCBT-I. The download rate of the VCBT-I was 78% (n=62/79). Several technical and contextual barriers to the delivery and the applicability of the VCBT-I emerged. However, participants reported a high level of satisfaction, and some valuable benefits at post-immediate intervention (increased knowledge about sleep, better quality of sleep, and higher acceptance of the burden of insomnia), regardless of whether or not they still had insomnia. This study confirms that there is a demand for a VCBT-I, which was perceived as appropriate by a sample of French cancer outpatients with insomnia, but it also highlights some limitations in terms of implementation and practicality. Remote professional support appears to be a core need in order to address these issues and personalize the guidance process.

Sections du résumé

BACKGROUND BACKGROUND
Insomnia affects up to 63% of patients with cancer. Cognitive behavioral therapy for insomnia (CBT-I) is considered to be the non-pharmacological gold standard treatment, but it remains underutilized in France. Self-administered interventions offer new ways to overcome some of the barriers that restrict access to efficacious supportive care.
OBJECTIVE OBJECTIVE
To assess the feasibility, among French adult cancer outpatients, of a validated Quebec video-based, self-administered, cognitive behavioral therapy for insomnia (VCBT-I).
METHODS METHODS
A pre-post design with quantitative measures (Insomnia Severity Index, Edmonton Symptom Assessment System, Treatment Perception Questionnaire) and qualitative measures (semi-structured interviews) was used.
RESULTS RESULTS
One hundred and seventy-three cancer outpatients were self-screened for insomnia, and 57% (n=99) reported significant symptoms. Among them, 80% (n=79) agreed to participate in the VCBT-I. The download rate of the VCBT-I was 78% (n=62/79). Several technical and contextual barriers to the delivery and the applicability of the VCBT-I emerged. However, participants reported a high level of satisfaction, and some valuable benefits at post-immediate intervention (increased knowledge about sleep, better quality of sleep, and higher acceptance of the burden of insomnia), regardless of whether or not they still had insomnia.
DISCUSSION CONCLUSIONS
This study confirms that there is a demand for a VCBT-I, which was perceived as appropriate by a sample of French cancer outpatients with insomnia, but it also highlights some limitations in terms of implementation and practicality. Remote professional support appears to be a core need in order to address these issues and personalize the guidance process.

Identifiants

pubmed: 33761001
doi: 10.1007/s00520-021-06151-7
pii: 10.1007/s00520-021-06151-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5883-5894

Subventions

Organisme : Institut National Du Cancer
ID : INCA RISP 2016 - N°2017-005

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Kwak A, Jacobs J, Haggett D, Jimenez R, Peppercorn J (2020) Evaluation and management of insomnia in women with breast cancer. Breast Cancer Res Treat 181(2):269–277. https://doi.org/10.1007/s10549-020-05635-0
doi: 10.1007/s10549-020-05635-0 pubmed: 32314110
Schieber K, Niecke A, Geiser F, Erim Y, Bergelt C, Büttner-Teleaga A, Maatouk I, Stein B, Teufel M, Wickert M, Wuensch A, Weis J (2019) The course of cancer-related insomnia: don’t expect it to disappear after cancer treatment. Sleep Med 58:107–113. https://doi.org/10.1016/j.sleep.2019.02.018
doi: 10.1016/j.sleep.2019.02.018 pubmed: 31146122
Savard J, Ivers H, Savard MH, Morin CM (2015) Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer 121(10):1703–1711. https://doi.org/10.1002/cncr.29244
doi: 10.1002/cncr.29244 pubmed: 25677509
Guzman-Marin R, Avidan AY (2015) Sleep disorders in patients with cancer. J Community Support Oncol 13(4):148–155. https://doi.org/10.12788/jcso.0126
doi: 10.12788/jcso.0126 pubmed: 25978413
Bean HR, Diggens J, Ftanou M, Weihs KL, Stanton AL, Wiley JF (2021) Insomnia and fatigue symptom trajectories in breast cancer: a longitudinal cohort study. Behav Sleep Med 20:1–14. https://doi.org/10.1080/15402002.2020.1869005
doi: 10.1080/15402002.2020.1869005
Liou KT, Ahles TA, Garland SN, Li QS, Bao T, Li Y, Root JC, Mao JJ (2019) The relationship between insomnia and cognitive impairment in breast cancer survivors. JNCI Cancer Spectr 73(3):pkz041. https://doi.org/10.1093/jncics/pkz041 eCollection 2019 Sep
doi: 10.1093/jncics/pkz041
Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep 29:1398–1414. https://doi.org/10.1093/sleep/29.11.1398
doi: 10.1093/sleep/29.11.1398 pubmed: 17162986
Howell D, Oliver TK, Keller-Olaman S, Davidson J, Garland S, Samuels C et al (2013) A Pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer 21(10):2695–2706. https://doi.org/10.1007/s00520-013-1823-6
doi: 10.1007/s00520-013-1823-6 pubmed: 23708820
Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28. https://doi.org/10.1016/j.smrv.2015.07.001
doi: 10.1016/j.smrv.2015.07.001 pubmed: 26434673
Ma Y, Hall DL, Ngo LH, Liu Q, Bain PA, Yeh GY (2020) Efficacy of cognitive behavioral therapy for insomnia in breast cancer: a meta-analysis. Sleep Med Rev:101376. https://doi.org/10.1016/j.smrv.2020.101376
Savard J, Villa J, Simard S, Ivers H, Morin CM (2011) Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology 20(9):1013–1019. https://doi.org/10.1002/pon.1818
doi: 10.1002/pon.1818 pubmed: 20677329
Savard J, Ivers H, Savard MH, Morin CM (2014) Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep 37(8):1305–1314. https://doi.org/10.5665/sleep.3918
doi: 10.5665/sleep.3918 pubmed: 25083010 pmcid: 4096199
Anderson KN, Goldsmith P, Gardiner A (2014) A pilot evaluation of an online cognitive behavioral therapy for insomnia disorder-targeted screening and interactive Web design lead to improved sleep in a community population. Nat Sci Sleep 6:43. https://doi.org/10.2147/NSS.S57852
doi: 10.2147/NSS.S57852 pubmed: 24669197 pmcid: 3962311
Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M (2009) How we design feasibility studies. Am J Prev Med 36(5):452–457. https://doi.org/10.1016/j.amepre.2009.02.002
doi: 10.1016/j.amepre.2009.02.002 pubmed: 19362699 pmcid: 2859314
Morin CM (1993) Insomnia: Psychological assessment and management. Guilford Press
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9. https://doi.org/10.1177/082585979100700202
doi: 10.1177/082585979100700202 pubmed: 1714502
Thomas DR (2006) A general inductive approach for analyzing qualitative evaluation data. Am J Eval 27(2):237–246. https://doi.org/10.1177/1098214005283748
doi: 10.1177/1098214005283748
Matthews EE, Schmiege SJ, Cook PF, Berger AM, Aloia MS (2012) Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav Sleep Med 10(3):217–229. https://doi.org/10.1080/15402002.2012.666220
doi: 10.1080/15402002.2012.666220 pubmed: 22742439
Prochaska JO, DiClemente CC (1982) Transtheoretical therapy: toward a more integrative model of change. Psychotherapy 19(3):276–288. https://doi.org/10.1037/h0088437
doi: 10.1037/h0088437
Hebert EA, Vincent N, Lewycky S, Walsh K (2010) Attrition and adherence in the online treatment of chronic insomnia. Behav Sleep Med 8(3):141–150. https://doi.org/10.1080/15402002.2010.487457
doi: 10.1080/15402002.2010.487457 pubmed: 20582757
Matthews EE, Schmiege SJ, Cook PF, Berger AM, Aloia MS (2012) Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav Sleep Med 10(3):217–229. https://doi.org/10.1080/15402002.2012.666220
doi: 10.1080/15402002.2012.666220 pubmed: 22742439
Chan C, West S, Glozier N (2017) Commencing and persisting with a web-based cognitive behavioral intervention for insomnia: a qualitative study of treatment completers. J Med Internet Res 19(2):e37. https://doi.org/10.2196/jmir.5639
doi: 10.2196/jmir.5639 pubmed: 28188124 pmcid: 5326082
Dozeman E, Verdonck-de Leeuw IM, Savard J, van Straten A (2017) Guided web-based intervention for insomnia targeting breast cancer patients: feasibility and effect. Internet Interv 9:1–6. https://doi.org/10.1016/j.invent.2017.03.005
doi: 10.1016/j.invent.2017.03.005 pubmed: 30135831 pmcid: 6096207
Zachariae R, Lyby MS, Ritterband LM, O'Toole MS (2016) Efficacy of internet-delivered cognitive-behavioral therapy for insomnia-a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 30:1–10. https://doi.org/10.1016/j.smrv.2015.10.004
doi: 10.1016/j.smrv.2015.10.004 pubmed: 26615572
Yeung WF, Chung KF, Ho FYY, Ho LM (2015) Predictors of dropout from internet-based self-help cognitive behavioral therapy for insomnia. Behav Res Ther 73:19–24. https://doi.org/10.1016/j.brat.2015.07.008
doi: 10.1016/j.brat.2015.07.008 pubmed: 26226091
Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD (2012) Initial evaluation of an internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology 21(7):695–705. https://doi.org/10.1002/pon.1969
doi: 10.1002/pon.1969 pubmed: 21538678
Zachariae R, Amidi A, Damholdt MF, Clausen CD, Dahlgaard J, Lord H et al (2018) Internet-delivered cognitive-behavioral therapy for insomnia in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst 110(8):880–887. https://doi.org/10.1093/jnci/djx293
doi: 10.1093/jnci/djx293 pubmed: 29471478 pmcid: 6093474

Auteurs

Diane Boinon (D)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France. diane.boinon@gustaveroussy.fr.
Université de Paris, LPPS, F-92100, Boulogne-Billancourt, France. diane.boinon@gustaveroussy.fr.

Cécile Charles (C)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.
Université de Paris, LPPS, F-92100, Boulogne-Billancourt, France.

Léonor Fasse (L)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.
Université de Paris, LPPS, F-92100, Boulogne-Billancourt, France.

Jonathan Journiac (J)

Université de Paris, LPPS, F-92100, Boulogne-Billancourt, France.

Gloria Pallubicki (G)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

Kristopher Lamore (K)

Université de Paris, LPPS, F-92100, Boulogne-Billancourt, France.

Grégory Ninot (G)

Institut Régional du Cancer de Montpellier, Montpellier, France.

Estelle Guerdoux-Ninot (E)

Institut Régional du Cancer de Montpellier, Montpellier, France.

Sébastien Gouy (S)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

Laurence Albiges (L)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

Suzette Delaloge (S)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

David Malka (D)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

David Planchard (D)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

Josée Savard (J)

School of Psychology, Université Laval, Québec, Canada.
Centre de recherche sur le cancer, Université Laval, Québec, Canada.
Centre de recherche du CHU de Québec-Université Laval, Québec, Canada.

Sarah Dauchy (S)

Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, F-94805, Villejuif Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH